The cardiometabolic syndrome is a concept recently developed by the American Heart Association to denote the totality of risk in a patient with risk factors that may lead to or worsen chronic kidney disease or cardiovascular events. A new validated scoring system has been endorsed by AHA to better assess the short and long-term risk for these in the general population.  We will discuss this scoring system in this podcast.The GameChangerA new validated scoring system has incorporated factors to better determine the 10 and 30 year risk of CVD and CKD in a general population.Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthMathew Boyd, PharmDClinical PharmacistUnity Point ReferenceGuidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001191Calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the concept of the Cardiovascular-Kidney-Metabolic syndrome. 2. Discuss how the PREVENT scoring system is applied to patients. 0.05 CEU/0.5 HrUAN: 0107-0000-24-075-H01-P  Initial release date: 3/4/2024Expiration date: 3/4/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Ver todos los episodios